Real-World Outcomes for Patients with Relapsed or Refractory (R/R) Aggressive B-Cell Non-Hodgkin's Lymphoma (aBNHL) Treated with Commercial Tisagenlecleucel: Subgroup Analyses from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Landsburg, Daniel J
  • Frigault, Matthew
  • Heim, Michael
  • Foley, Ronan
  • Hill, Brian T
  • Ho, Christine M
  • Jacobson, Caron A
  • Jaglowski, Samantha
  • Locke, Frederick L
  • Ram, Ron
  • Riedell, Peter A
  • Shah, Gunjan L
  • Popplewell, Leslie L
  • Tiwari, Ranjan
  • Lim, Stephen
  • Majdan, Marta
  • Masood, Aisha
  • Pasquini, Marcelo C
  • Turtle, Cameron J

publication date

  • November 15, 2022

published in